Hydrotropic magnetic micelles for combined magnetic resonance imaging and cancer therapy

Hong Yeol Yoon, Gurusamy Saravanakumar, Roun Heo, Seung Hong Choi, In Chan Song, Moon Hee Han, Kwang Meyung Kim, Jae Hyung Park, Kuiwon Choi, Ick Chan Kwon, Kinam Park

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Polymeric nanoparticles, capable of encapsulating imaging agents and therapeutic drugs, have significant advantages for simultaneous diagnosis and therapy. Nonetheless, improvements in the loading contents of the active agents are needed to achieve enhanced imaging and effective therapeutic outcomes. Aiming to make these improvements, a hydrotropic micelle (HM) was explored to encapsulate superparamagnetic iron oxide nanoparticles (SPIONs) as the magnetic resonance (MR) imaging agent and paclitaxel (PTX) as the hydrophobic anticancer drug. Owing to its hydrotropic inner core with hydrophobic nature, HM could effectively encapsulate both of PTX and SPION via the simple dialysis method. The hydrodynamic size of HM increased from 68 to 178 nm after physical encapsulation of SPION and PTX. Transmission electron microscopy analysis of HM bearing SPION and PTX (HM-SPION-PTX) revealed a spherical morphology with SPION clusters in the micelle cores. The micelles released PTX in a sustained manner. The bare HM and HM-SPION showed no toxicity to SCC7 cells, whereas HM-PTX and HM-SPION-PTX showed dose-dependent cytotoxicity that was lower than free PTX. HM-SPION-PTX exhibited 8.1-fold higher T 2 relaxivity than HM-SPION, implying potential of HM-SPION-PTX as the contrast agent for MR imaging. When systemically administered to tumor-bearing mice, HM-SPION-PTX was effectively accumulated at the tumor site, allowing its detection using MR imaging and effective therapy. Overall, these results suggested that HM-SPION-PTX is a promising candidate for combined diagnosis and treatment of cancer.

Original languageEnglish
Pages (from-to)692-698
Number of pages7
JournalJournal of Controlled Release
Volume160
Issue number3
DOIs
Publication statusPublished - 2012 Jun 28
Externally publishedYes

Fingerprint

Micelles
Paclitaxel
Nanoparticles
Magnetic Resonance Imaging
Neoplasms
Therapeutics
ferric oxide
Hydrodynamics
Transmission Electron Microscopy
Pharmaceutical Preparations
Contrast Media
Dialysis

Keywords

  • Drug delivery
  • Hydrotropic micelle
  • Magnetic resonance imaging
  • Paclitaxel

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Yoon, H. Y., Saravanakumar, G., Heo, R., Choi, S. H., Song, I. C., Han, M. H., ... Park, K. (2012). Hydrotropic magnetic micelles for combined magnetic resonance imaging and cancer therapy. Journal of Controlled Release, 160(3), 692-698. https://doi.org/10.1016/j.jconrel.2012.04.012

Hydrotropic magnetic micelles for combined magnetic resonance imaging and cancer therapy. / Yoon, Hong Yeol; Saravanakumar, Gurusamy; Heo, Roun; Choi, Seung Hong; Song, In Chan; Han, Moon Hee; Kim, Kwang Meyung; Park, Jae Hyung; Choi, Kuiwon; Kwon, Ick Chan; Park, Kinam.

In: Journal of Controlled Release, Vol. 160, No. 3, 28.06.2012, p. 692-698.

Research output: Contribution to journalArticle

Yoon, HY, Saravanakumar, G, Heo, R, Choi, SH, Song, IC, Han, MH, Kim, KM, Park, JH, Choi, K, Kwon, IC & Park, K 2012, 'Hydrotropic magnetic micelles for combined magnetic resonance imaging and cancer therapy', Journal of Controlled Release, vol. 160, no. 3, pp. 692-698. https://doi.org/10.1016/j.jconrel.2012.04.012
Yoon, Hong Yeol ; Saravanakumar, Gurusamy ; Heo, Roun ; Choi, Seung Hong ; Song, In Chan ; Han, Moon Hee ; Kim, Kwang Meyung ; Park, Jae Hyung ; Choi, Kuiwon ; Kwon, Ick Chan ; Park, Kinam. / Hydrotropic magnetic micelles for combined magnetic resonance imaging and cancer therapy. In: Journal of Controlled Release. 2012 ; Vol. 160, No. 3. pp. 692-698.
@article{1124aa324028499cae799e98c4cf0f1e,
title = "Hydrotropic magnetic micelles for combined magnetic resonance imaging and cancer therapy",
abstract = "Polymeric nanoparticles, capable of encapsulating imaging agents and therapeutic drugs, have significant advantages for simultaneous diagnosis and therapy. Nonetheless, improvements in the loading contents of the active agents are needed to achieve enhanced imaging and effective therapeutic outcomes. Aiming to make these improvements, a hydrotropic micelle (HM) was explored to encapsulate superparamagnetic iron oxide nanoparticles (SPIONs) as the magnetic resonance (MR) imaging agent and paclitaxel (PTX) as the hydrophobic anticancer drug. Owing to its hydrotropic inner core with hydrophobic nature, HM could effectively encapsulate both of PTX and SPION via the simple dialysis method. The hydrodynamic size of HM increased from 68 to 178 nm after physical encapsulation of SPION and PTX. Transmission electron microscopy analysis of HM bearing SPION and PTX (HM-SPION-PTX) revealed a spherical morphology with SPION clusters in the micelle cores. The micelles released PTX in a sustained manner. The bare HM and HM-SPION showed no toxicity to SCC7 cells, whereas HM-PTX and HM-SPION-PTX showed dose-dependent cytotoxicity that was lower than free PTX. HM-SPION-PTX exhibited 8.1-fold higher T 2 relaxivity than HM-SPION, implying potential of HM-SPION-PTX as the contrast agent for MR imaging. When systemically administered to tumor-bearing mice, HM-SPION-PTX was effectively accumulated at the tumor site, allowing its detection using MR imaging and effective therapy. Overall, these results suggested that HM-SPION-PTX is a promising candidate for combined diagnosis and treatment of cancer.",
keywords = "Drug delivery, Hydrotropic micelle, Magnetic resonance imaging, Paclitaxel",
author = "Yoon, {Hong Yeol} and Gurusamy Saravanakumar and Roun Heo and Choi, {Seung Hong} and Song, {In Chan} and Han, {Moon Hee} and Kim, {Kwang Meyung} and Park, {Jae Hyung} and Kuiwon Choi and Kwon, {Ick Chan} and Kinam Park",
year = "2012",
month = "6",
day = "28",
doi = "10.1016/j.jconrel.2012.04.012",
language = "English",
volume = "160",
pages = "692--698",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Hydrotropic magnetic micelles for combined magnetic resonance imaging and cancer therapy

AU - Yoon, Hong Yeol

AU - Saravanakumar, Gurusamy

AU - Heo, Roun

AU - Choi, Seung Hong

AU - Song, In Chan

AU - Han, Moon Hee

AU - Kim, Kwang Meyung

AU - Park, Jae Hyung

AU - Choi, Kuiwon

AU - Kwon, Ick Chan

AU - Park, Kinam

PY - 2012/6/28

Y1 - 2012/6/28

N2 - Polymeric nanoparticles, capable of encapsulating imaging agents and therapeutic drugs, have significant advantages for simultaneous diagnosis and therapy. Nonetheless, improvements in the loading contents of the active agents are needed to achieve enhanced imaging and effective therapeutic outcomes. Aiming to make these improvements, a hydrotropic micelle (HM) was explored to encapsulate superparamagnetic iron oxide nanoparticles (SPIONs) as the magnetic resonance (MR) imaging agent and paclitaxel (PTX) as the hydrophobic anticancer drug. Owing to its hydrotropic inner core with hydrophobic nature, HM could effectively encapsulate both of PTX and SPION via the simple dialysis method. The hydrodynamic size of HM increased from 68 to 178 nm after physical encapsulation of SPION and PTX. Transmission electron microscopy analysis of HM bearing SPION and PTX (HM-SPION-PTX) revealed a spherical morphology with SPION clusters in the micelle cores. The micelles released PTX in a sustained manner. The bare HM and HM-SPION showed no toxicity to SCC7 cells, whereas HM-PTX and HM-SPION-PTX showed dose-dependent cytotoxicity that was lower than free PTX. HM-SPION-PTX exhibited 8.1-fold higher T 2 relaxivity than HM-SPION, implying potential of HM-SPION-PTX as the contrast agent for MR imaging. When systemically administered to tumor-bearing mice, HM-SPION-PTX was effectively accumulated at the tumor site, allowing its detection using MR imaging and effective therapy. Overall, these results suggested that HM-SPION-PTX is a promising candidate for combined diagnosis and treatment of cancer.

AB - Polymeric nanoparticles, capable of encapsulating imaging agents and therapeutic drugs, have significant advantages for simultaneous diagnosis and therapy. Nonetheless, improvements in the loading contents of the active agents are needed to achieve enhanced imaging and effective therapeutic outcomes. Aiming to make these improvements, a hydrotropic micelle (HM) was explored to encapsulate superparamagnetic iron oxide nanoparticles (SPIONs) as the magnetic resonance (MR) imaging agent and paclitaxel (PTX) as the hydrophobic anticancer drug. Owing to its hydrotropic inner core with hydrophobic nature, HM could effectively encapsulate both of PTX and SPION via the simple dialysis method. The hydrodynamic size of HM increased from 68 to 178 nm after physical encapsulation of SPION and PTX. Transmission electron microscopy analysis of HM bearing SPION and PTX (HM-SPION-PTX) revealed a spherical morphology with SPION clusters in the micelle cores. The micelles released PTX in a sustained manner. The bare HM and HM-SPION showed no toxicity to SCC7 cells, whereas HM-PTX and HM-SPION-PTX showed dose-dependent cytotoxicity that was lower than free PTX. HM-SPION-PTX exhibited 8.1-fold higher T 2 relaxivity than HM-SPION, implying potential of HM-SPION-PTX as the contrast agent for MR imaging. When systemically administered to tumor-bearing mice, HM-SPION-PTX was effectively accumulated at the tumor site, allowing its detection using MR imaging and effective therapy. Overall, these results suggested that HM-SPION-PTX is a promising candidate for combined diagnosis and treatment of cancer.

KW - Drug delivery

KW - Hydrotropic micelle

KW - Magnetic resonance imaging

KW - Paclitaxel

UR - http://www.scopus.com/inward/record.url?scp=84861962638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861962638&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2012.04.012

DO - 10.1016/j.jconrel.2012.04.012

M3 - Article

VL - 160

SP - 692

EP - 698

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 3

ER -